Skip to site content

GPRA Report Summary 2017

The GPRA dashboard is published yearly.

A continuing emphasis on community oral health promotion/disease prevention is essential in order to address the current high prevalence, reduce the severity of oral disease and improve the oral health of American Indian/Alaska Native (AI/AN) people.

Access to dental services is a prerequisite for the control of oral disease in susceptible or high-risk populations.

The access to care measure is currently aligned with Healthy People 2020 as a percentage of patients who have visited the dentist within the previous 12 months.

Topical fluorides and dental sealants have been extensively researched and documented in the dental literature as safe and effective preventive interventions to reduce tooth decay.

ACCESS TO DENTAL SERVICES

29.5%
2017 Final
29.7% National Target

DENTAL SEALANTS

18.5%

2017 Final
16.6% National Target

TOPICAL FLUORIDE

31.9%

2017 Final
29.9% National Target

Diabetes prevention and treatment efforts are important priorities to decrease the onset of diabetes and its complications.

Controlling blood pressure reduces the risk that diabetic patients will develop heart disease, stroke, and kidney failure.

Adequate control of blood sugar levels reduces the risk that patients will develop complications of diabetes, such as heart, blood vessel, eye, kidney, and nerve problems.

Nephropathy assessments help to identify patients who are at risk for kidney disease.

Retinopathy assessments help to identify diabetic patients who are at higher risk for developing blindness.

People with diabetes have an increased risk of heart disease and stroke. Medications called statins help reduce this risk.

CONTROLLED BLOOD PRESSURE <140/90

67.6%
2017 Final
63.8% National Target

GOOD GLYCEMIC CONTROL

46.1%

2017 Final
48.4% National Target

NEPHROPATHY ASSESSED

64.5%

2017 Final
63.3% National Target

RETINOPATHY EXAM

61.4%

2017 Final
63.1% National Target

STATIN THERAPY

64.2%

2017 Final
61.9% National Target

Routine immunizations represent a cost-effective public health approach to protect individuals from preventable infectious diseases.

IHS tracked four immunizations nationally in 2017.

Two measures targeted children: annual influenza vaccination for children 6 months to 17 years and a combined (4:3:1:3:3:1:4) childhood series for children 19 – 35 months.

Two adult vaccination measures are included: annual influenza vaccination for adults 18+ and pneumococcal vaccination for adults 65+.

CHILDHOOD IMMUNIZATIONS

70.9%
2017 Final
74.8% National Target

INFLUENZA VACCINATION 6 MO-17 YRS

37.2%

2017 Final
37.1% National Target

INFLUENZA VACCINATION 18+

39.2%

2017 Final
38.7% National Target

PNEUMOCOCCAL VACCINATION 65+

86.8%

2017 Final
86.7% National Target

Prevention measures focus attention on early detection of disease (cancer screenings) and management of risk factors to prevent disease (tobacco cessation and HIV screening).

Prevention can focus on appropriate treatment of chronic conditions (cholesterol and blood pressure treatment) to avoid complications.

Prevention also focuses on healthy behaviors/lifestyles (childhood weight control and infant breastfeeding) that have been shown to prevent diseases.

(CERVICAL) PAP SCREENING

54.8%
2017 Final
56.1% National Target

COLORECTAL CANCER SCREENING

41.4%

2017 Final
40.2% National Target

MAMMOGRAPHY SCREENING

55.4%

2017 Final
56.7% National Target

TOBACCO CESSATION

52.2%

2017 Final
53.2% National Target

HIV SCREENING EVER

45.1%

2017 Final
41.9% National Target

CVD STATIN THERAPY

48.1%

2017 Final
Baseline National Target

CONTROLLING HIGH BLOOD PRESSURE-MILLION HEARTS

59.0%

2017 Final
59.7% National Target

CHILDHOOD WEIGHT CONTROL

22.8%

2017 Final
N/A National Target

BREASTFEEDING RATES

40.1%

2017 Final
36.4% National Target

High rates of alcohol and substance abuse, mental health disorders, suicide, violence, and behavior-related chronic diseases in American Indian and Alaska Native (AI/AN) communities are well documented.

Each of these serious behavioral health issues has a profound impact on the health of individuals, families, and communities.

Two measures relate to alcohol screening or identifying patients with risky or harmful alcohol use and provide them with a brief negotiated interview.

Two depression screening measures span ages 12 and older.

Two antidepressant medication management measures count patients who take antidepressant medication for 12 weeks (acute phase treatment) and those who take medication up to 6 months (continuation phase treatment).

The intimate partner (domestic) violence (IPV/DV) measure identifies women 14 – 46 years who have been screened for IPV/DV.

UNIVERSAL ALCOHOL SCREENING

68.0%
2017 Final
Baseline National Target

ANTIDEPRESSANT MEDICATION MANAGEMENT: ACUTE TREATMENT

41.9%
2017 Final
Baseline National Target

ANTIDEPRESSANT MEDICATION MANAGEMENT: CONTINUOUS TREATMENT

21.9%
2017 Final
Baseline National Target

INTIMATE PARTNER VIOLENCE/DOMESTIC VIOLENCE SCREENING

66.6%
2017 Final
65.3% National Target

DEPRESSION SCREENING 12-17 YRS

50.1%
2017 Final
Baseline National Target

DEPRESSION SCREENING 18+

69.4%
2017 Final
70.0% National Target

SCREENING, BRIEF INTERVENTION & REFERRAL TO TREATMENT

3.0%
2017 Final
Baseline National Target